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readmitted 18 days later with nasal 
congestion, cough, and high fever. 
PCR results were again positive for 
pandemic (H1N1) 2009, and the pa-
tient was successfully treated with 
oseltamivir. 
Patient 2 and probably patient 3 
acquired their infections while hospi-
talized, suggesting potential nosoco-
mial transmission. No other respira-
tory viruses were found in any of these 
patients. The viral isolates were all 
tested (LightMix for detection of in-
ﬂ  uenza A virus oseltamivir resistance 
[H274Y]; TIB MOLBIOL) for possi-
ble resistance to oseltamivir, but none 
had the resistance-implicated H274Y 
mutation in the neuraminidase gene
Shedding of seasonal inﬂ  uenza A 
virus ceases within 5–7 days during 
natural infection and during infections 
treated with neuraminidase inhibitors 
(4). Although clearing of virus after 
the ﬁ  rst infection was not documented 
in the 3 patients described here, it is 
unlikely that virus persisted between 
the 2 episodes of inﬂ  uenza since each 
of the patients fully recovered after 
speciﬁ  c antiviral drug treatment. How-
ever, we cannot rule out that patient 2 
may have never cleared the virus due 
to her immune suppression. 
As described by mathematical 
modeling (5), the 3 patients described 
were susceptible to reinfection with 
pandemic (H1N1) 2009 due to the 
high rate of community infection and 
to their incomplete immunologic pro-
tection within the period of reexpo-
sure. During the current pandemic of 
inﬂ   uenza subtype H1N1, healthcare 
workers and patients should be aware 
that symptomatic reinfection might 
occur after a ﬁ  rst episode of infection.
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Skin Lesion Caused 
by ST398 and ST1 
MRSA, Spain1
To the Editor: Human infections 
caused by methicillin-resistant Staph-
ylococcus aureus (MRSA) sequence 
type 398 (ST398) have been emerg-
ing in recent years in Europe (1,2). 
Pigs represent a common reservoir 
of MRSA ST398, and working with 
these animals may constitute a risk 
factor for MRSA carriage and pos-
sible infection (2–4). We report a case 
of human infection caused by MRSA 
ST398 in Spain.
A 12-year-old girl living close 
to a pig farm, where her father and 
mother worked, sought treatment for 
a skin lesion on her chin. Two types 
of MRSA were recovered from the 
lesion, and it resolved after topical 
treatment with mupirocin over 10 
days. MRSA isolates recovered were 
characterized by multilocus sequence 
typing (MLST) and by staphylococ-
cal cassette chromosome (SCC) mec, 
spa, and agr  typing as described 
(3). The presence of genes encoding 
Panton-Valentine leukocidin (PVL) 
(lukF/lukS), toxic shock syndrome 
toxin-1 (tsst1), and exfoliative-toxin 
A and B (eta, etb) was investigated by 
PCR (2,3). Antimicrobial susceptibil-
ity tests were carried out by using the 
VITEK-2 system (bioMérieux, Marcy 
l’Etoile, France), and mecA,  ermA, 
ermB, ermC, mrsA, tetK, tetL, tetM, 
ant(4′)-Ia,  aph(3′)-III , and aph(2′)-
aac(6′) resistance genes were stud-
ied by PCR (5). dfrK gene detection 
was performed by using primers de-
signed from the sequence FM207105 
included in GenBank (dfrK-F 5′-
GAGAATCCCAGAGGATTGGG; 
dfrK-R, 5′-CAAGAAGCTTTTCGCT
CATAAA), and the obtained ampli-
cons were sequenced for conﬁ  rma-
tion. Mutations in quinolone targets 
were determined by sequence analy-
sis of grlA and gyrA genes (6). In 
addition, MRSA isolates were typed 
by pulsed-ﬁ   eld gel electrophoresis 
(PFGE) (www.harmony-microbe.net/
microtyping.htm).
One of the clinical MRSA isolates 
recovered from the lesion and typed as 
ST398-spa-t011 showed resistance to 
tetracycline, macrolides, and lincos-
amides and harbored 5 antimicrobial 
resistance genes. The second MRSA 
strain was typed as ST1-spa-t127 and 
showed a multiresistance phenotype 
with 11 resistance genes, as well as the 
Ser80Phe and Ser84Leu amino acid 
changes in GrlA and GyrA proteins, 
respectively.
To establish the MRSA nasal 
colonization status of the patient and 
of her relatives (father, mother, and 
brother, all of whom had contact with 
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animals) and to elucidate the possible 
origin of these strains, we analyzed 
nasal swabs for MRSA recovery. Na-
sal samples were plated in oxacillin-
resistant S. aureus agar media (ORSA, 
Termoﬁ   sher, UK), colistin nalidixic 
acid agar media (bioMérieux), and 
blood agar media (Oxoid); colonies 
suggestive of S. aureus were initially 
selected, further identiﬁ  ed, and char-
acterized for bacterial typing and an-
timicrobial resistance mechanisms. 
Samples from all relatives and the 
patient showed that all 4 persons 
were MRSA nasal carriers present-
ing the following genetic lineages: 
patient girl, ST398-t108; mother, 
ST398-t108 and ST1-t127; father, 
ST398-t108; and brother, ST398-t011 
(2 variants) (Table). MRSA t127 and 
t011 variants detected in the skin le-
sion of the patient were not found in 
her nasal sample but were found in 
the nasal samples of her mother and 
brother. Another study has been initi-
ated to analyze the presence of MRSA 
in nasal swabs of swine on the farm.
The ST1-t127 strains obtained 
from the skin lesion of the girl (C1569) 
and from the mother’s nasal sample 
(C1578) showed the same multiresis-
tance phenotype and genotype (Table) 
and an indistinguishable PFGE pattern. 
This clonal type seems to be associ-
ated with community-acquired MRSA 
isolates circulating in Europe (7). The 
animal origin of this MRSA type and 
its possible transmission from horses 
and cows to humans has been suggest-
ed in previous reports (8,9).
In addition, all family members 
were colonized by MRSA ST398. All 
recovered nasal MRSA ST398 strains 
showed resistance to β-lactams, mac-
rolides, lincosamide, and tetracycline, 
and 3 strains also showed diminished 
susceptibility to quinolones. Strain 
ST398 C1576, recovered from the 
brother, showed a multiresistance phe-
notype (Table).
The ST398 strains of our study 
were classiﬁ  ed in the spa-types t011 
and t108, 2 of the most frequently de-
scribed types of the clonal complex 
398 (1,4) and were untypeable by 
PFGE. Most MRSA ST398 strains in 
our study showed a resistance pheno-
type that included tetracycline, mac-
rolides, and lincosamides. Tetracy-
cline resistance is a common trait of 
ST398 and suggests that its use in vet-
erinary medicine may have been im-
plicated in selection of this resistance. 
The  ﬁ   rst reports, describing ST398 
strains, indicated β-lactams and tetra-
cycline as the unique resistance mark-
ers, which were susceptible to other 
antimicrobial agents. Nevertheless, re-
ports of ST398 showing resistance to 
other antimicrobial drugs are increas-
ing. One of the ST398 strains from the 
brother showed an uncommon multi-
resistance phenotype. Moreover, all 
the MRSA strains of this study were 
negative for all tested toxin genes, 
included PVL, although some ST398 
PVL–positive strains have been occa-
sionally described (10).
We report a skin lesion on the 
daughter of a pig farmer in Spain asso-
ciated with ST398-t011 and ST1-t127 
MRSA strains. The results obtained 
suggest the speciﬁ  c animal origin of 
these strains and subsequent trans-
ference among family members. Of 
special interest is the multiresistance 
phenotype of the clinical and nasal 
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Table. Characteristics of the 9 MRSA strains recovered in Spain from a patient’s lesion and from nasal samples obtained from 
patient’s family members* 
Amino acid 
change in: 
Strain
Origin of 
sample
SCCmec
type MLST
spa
type  agr
Antimicrobial resistance 
phenotype  Resistance genes detected  GrlA GyrA 
C1570 Patient/
skin lesion 
V ST398 t011 I OXA, FOX, TET, ERY, 
CLI, TEL 
mecA, tetK, ermA, ermC, msrA  NP NP
C1569 Patient/
skin lesion 
II ST1 t127 III OXA, FOX, TET, ERY, 
CLI, TEL, GEN, TOB, 
KAN, CIP, LEV, SXT 
mecA, tetL, tetK, ermA, ermB, 
ermC, msrA, aph(2’)-acc(6’), 
ant(4´)-Ia, aph (3’), dfrK 
S80F S84L
C1571 Patient/
nasal swab 
V ST398 t108 I OXA, FOX, TET, ERY, 
CLI, TEL, CIP†, LEV† 
mecA, tetK, tetL, tetM, ermA, 
ermC, msrA 
Wild Wild
C1577 Mother/
nasal swab 
V ST398 t108 I OXA, FOX, TET, ERY, 
CLI, TEL, CIP†, LEV† 
mecA, tetK, tetM, ermA, ermC, 
msrA 
Wild Wild
C1578 Mother/
nasal swab 
II ST1 t127 III OXA, FOX, TET, ERY, 
CLI, TEL, GEN, TOB, 
KAN, CIP, LEV, SXT 
mecA, tetL, tetK, ermA, ermB, 
ermC, msrA, aph(2’)-acc(6’), 
ant(4´)-Ia, aph (3’), dfrK 
S80F S84L
C1574 Brother/
nasal swab 
V ST398 t011 I OXA, FOX, TET, ERY, 
CLI, TEL 
mecA, tetK, ermA, ermC, msrA  NP NP
C1576 Brother/
nasal swab 
V ST398 t011 I OXA, FOX, TET, ERY, 
CLI, TEL, GEN, TOB, 
KAN, SXT 
mecA, tetL, tetK, ermA, ermB, 
ermC, msrA, aph(2’)-acc(6’), 
ant(4´)-Ia, aph (3’), dfrK 
NP NP
C1572 Father/
nasal swab 
V ST398 t108 I OXA, FOX, TET, ERY, 
CLI, TEL, CIP†, LEV† 
mecA, tetK, tetL, tetM, ermA, 
ermC, msrA 
Wild Wild
*MRSA, methicillin resistant Staphylococcus aureus; SCC, staphylococcal cassette chromosome; MLST, multilocus sequence typing; ST, sequence type; 
OXA, oxacillin; FOX, cefoxitin; TET, tetracycline; ERY, erythromycin; CLI, clindamycin; TEL, telithromycin; NP, not performed; GEN, gentamicin; TOB, 
tobramycin; KAN, kanamycin; CIP, ciprofloxacin; LEV, levofloxacin; SXT, sulfamethoxazole-trimethoprim. 
†Iintermediate category for the indicated antimicrobial drug. LETTERS
ST1-t127 MRSA clinical strains and 
of 1 nasal strain belonging to ST398 
lineage. Nasal colonization by dif-
ferent ST398 genetic lineages and by 
other lineages of MRSA as ST1-t127 
seems to be frequent in persons living 
in close proximity to farm animals. 
Dissemination of MRSA ST398 (and 
probably also MRSA ST1) in humans 
who have contact with farm animals, 
is an emerging problem in Spain.  
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Identiﬁ  cation of 
a Rotavirus G12 
Strain, Indonesia
To the Editor: Group A rotavi-
ruses are the most common etiologic 
agents of acute gastroenteritis in in-
fants and young children, each year 
resulting in ≈100 million diarrhea ep-
isodes and 600,000 deaths worldwide 
(1). The genome of rotavirus com-
prises 11 segments of double-stranded 
RNA, which encode 6 structural viral 
proteins (VPs) and 6 nonstructural 
proteins (NSPs). Recent scientiﬁ  c 
reports have identiﬁ  ed novel rotavi-
rus strains, such as G12 (2–5), which 
were  ﬁ  rst described in 1987 among 
Filipino children with diarrhea (6). In 
Indonesia, a rotavirus study showed 
that a broad variety of VP7 types (G1, 
G2, G3, G4, G8, G9) and VP4 types 
(P[4], P[6], P[8], P[9], P[10], P[11]), 
especially G9 and P[8] and G9P[8], 
were the genotype combinations most 
frequently encountered (7).
From 2005 through 2008, we 
conducted a nationwide surveillance 
study among children who had diar-
rhea to determine etiologies among 
Indonesian children seeking health 
services for diarrhea at hospitals and 
health clinics. Patients were enrolled 
after obtaining consent from parents/
guardians of those eligible in accor-
dance with an institutional review 
board protocol approved by the US 
Naval Medical Research Unit No. 2 
(NAMRU-2) and the Ethical Commit-
tee of the Indonesian National Health 
Research and Development Institute. 
Stool specimens and clinical enroll-
ment data were collected for each eli-
gible patient, and all collected items 
were transported to NAMRU-2 in Ja-
karta, Indonesia. In December 2007, a 
stool specimen was collected from a 
14-day-old afebrile infant brought to 
Sumber Waras Hospital in West Jakar-
ta with diarrhea, vomiting, moderate 
dehydration, and malnutrition. This 
patient was infected with the rotavi-
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